These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21322752)
21. Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer. Hombach AA; Abken H Immunotherapy; 2013 Jul; 5(7):677-81. PubMed ID: 23829616 [No Abstract] [Full Text] [Related]
22. Breast cancer immunotherapy. Zhou J; Zhong Y Cell Mol Immunol; 2004 Aug; 1(4):247-55. PubMed ID: 16225767 [TBL] [Abstract][Full Text] [Related]
23. Genetically modulating T-cell function to target cancer. Merhavi-Shoham E; Haga-Friedman A; Cohen CJ Semin Cancer Biol; 2012 Feb; 22(1):14-22. PubMed ID: 22210183 [TBL] [Abstract][Full Text] [Related]
24. [T-cell therapy in oncology. Therapeutic vaccination, allogeneic blood stem cell transplantation and adoptive T-cell transfer]. Kuball J; Derigs HG; Wölfel T Dtsch Med Wochenschr; 2002 Apr; 127(14):755-62. PubMed ID: 11935475 [No Abstract] [Full Text] [Related]
25. Prospects and limitations of T cell receptor gene therapy. Coccoris M; de Witte MA; Schumacher TN Curr Gene Ther; 2005 Dec; 5(6):583-93. PubMed ID: 16457648 [TBL] [Abstract][Full Text] [Related]
26. Ancient Retrovirus Targeted by Engineered T Cells in Melanoma--Letter. Grange JM; Krone B Clin Cancer Res; 2015 Oct; 21(19):4494. PubMed ID: 26429983 [No Abstract] [Full Text] [Related]
27. Genetically engineered T cells as adoptive immunotherapy of cancer. Ma Q; Gonzalo-Daganzo RM; Junghans RP Cancer Chemother Biol Response Modif; 2002; 20():315-41. PubMed ID: 12703212 [No Abstract] [Full Text] [Related]
28. [Tumor-infiltrating lymphocytes (TIL)]. Matysiak W Pol Arch Med Wewn; 1995 Jul; 94(1):76-83. PubMed ID: 8524702 [No Abstract] [Full Text] [Related]
29. Toward Clinical Translation of New Gene Targeting Technologies for Correcting Inherited Mutations and Empowering Adoptive Immunotherapy of Cancer (SUPERSIST). Hum Gene Ther Clin Dev; 2015 Jun; 26(2):95-7. PubMed ID: 26086760 [No Abstract] [Full Text] [Related]
30. Blockade of TGF-β signaling greatly enhances the efficacy of TCR gene therapy of cancer. Bendle GM; Linnemann C; Bies L; Song JY; Schumacher TN J Immunol; 2013 Sep; 191(6):3232-9. PubMed ID: 23940272 [TBL] [Abstract][Full Text] [Related]
31. Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future. Peinert S; Kershaw MH; Prince HM Immunotherapy; 2009 Nov; 1(6):905-12. PubMed ID: 20635906 [No Abstract] [Full Text] [Related]
32. [Application of gene therapy in tumor adoptive immunotherapy]. Wang C; Zhao Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):482-6. PubMed ID: 18610648 [TBL] [Abstract][Full Text] [Related]
33. The promise of T-lymphocyte immunotherapy for the treatment of malignant disease. Thomas AK; June CH Cancer J; 2001; 7 Suppl 2():S67-75. PubMed ID: 11777267 [TBL] [Abstract][Full Text] [Related]
34. Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma. Samaha H; El Naggar S; Ahmed N Immunotherapy; 2015; 7(5):481-5. PubMed ID: 26065474 [No Abstract] [Full Text] [Related]
35. Dendritic cells: a journey from laboratory to clinic. Cerundolo V; Hermans IF; Salio M Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398 [No Abstract] [Full Text] [Related]